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Ab~ra~ 
Recent studies have demonstrated that preincubation of SK-Mel-28 melanoma cells with ferric ammonium citrate (FAC) resulted in 
59 59 125 marked stimulation of Fe uptake from Fe- I-transferrin (Tf), but only at Tf concentrations above that required for saturation of the 
Tf receptor (Richardson and Baker (1992) J. Biol. Chem. 267, 13972-13979). The mechanism responsible for this stimulation was 
unknown and is the subject of the present report. Preincubation of cells with FAC (25 /zg/ml), followed by a 2 h incubation with 
59Fe-125I-Tf (0.1 mg/ml; 1.25 /xM), resulted in temperature-dependent 59Feuptake to approx. 200% of the control value. Furthermore, 
the effect was not specific for melanoma cells and was also observed in other normal and neoplastic ells. Preincubation of melanoma 
cells with FAC also stimulated 59Fe uptake from 59Fe-citrate, but to a far greater extent han that observed with 59Fe-JZSI-Tf (viz., > 
20-fold that seen for the control). Interestingly, neither receptor-mediated endocytosis nor the postulated iferric Tf reductase were 
involved in the FAC-activated Fe uptake process from Tf. However, the addition of free radical scavengers to FAC such as catalase, 
superoxide dismutase, ceruloplasmin, Hepes, mannitol and high concentrations of BSA or ascorbate, markedly depressed FAC-activated 
59Fe uptake from 59Fe-125I-Tf and 59Fe-citrate. These agents when added to control cells had no effect on 59Fe uptake. The addition of 
superoxide generating agents ~nd hydrogen peroxide to minimum essential medium (MEM) containing FAC but not to MEM alone, also 
stimulated 59Fe uptake. These: data suggest hat the initial activation of the FAC-stimulated Fe uptake system was caused by the 
production of hydroxyl radicals via the Fe-catalysed Haber-Weiss reaction. We propose that this Fe uptake process represents an 
important cellular defense mechanism against oxidant stress generated in the presence of low-molecular-weight Fe complexes. 
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1. Introduction 
Iron (Fe) containing proteins catalyse key reactions 
involving energy metabolism, respiration and DNA synthe- 
sis [1]. Donation of Fe to cells occurs following the 
binding of Tf to the transferrin receptor (TfR) on the cell 
membrane. The Tf-TfR complex is then internalised by 
receptor-mediated ndocytosis (RME), and Fe is released 
Abbreviations: DFO, desferfioxamine; FAC, ferric ammonium citrate; 
gPR, gram of protein; MB, methylene blue; MEM, minimum essential 
medium; RME, receptor-mediated en ocytosis; SOD, superoxide dismu- 
tase; Tf, transferrin; TfR, transferrin receptor. 
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from Tf  by a process involving endosomal acidification 
and reduction [2-4]. In addition to this well characterised 
mechanism, several investigators have also reported an 
alternate process mediated by a surface-bound 
NADH:ferricyanide oxidoreductase [5-9]. However, the 
role of an oxidoreductase (diferric Tf reductase) in Fe 
uptake from Tf is poorly defined, and further characterisa- 
tion of this process is required, as the results remain 
controversial [ 10,11 ]. 
Apart from Tf-bound Fe uptake, mammalian cells also 
possess a high capacity, membrane-bound, Fe-transport 
system capable of efficiently obtaining Fe from small 
molecular weight (M r) complexes [ 12-16]. Incubation of a 
wide variety of cell types with the Fe complex, ferric 
ammonium citrate (FAC), results in the activation of a 
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membrane-bound Fe transport system [17] that may be at 
least partly responsible for the Fe uptake observed in 
hypotransferrinemia and Fe overload isease [ 15,18]. 
Our previous studies investigating the Fe uptake pro- 
cesses of the human melanoma cell line, SK-MEL-28, 
demonstrated two separate Fe uptake mechanisms from Tf 
[19]. The first process was consistent with RME which 
saturated at a Tf concentration of 0.01 mg/ml (0.125 
/xM), and was mediated by a single high affinity Tf 
binding site. The second Fe uptake process was saturable 
at much higher Tf concentrations (0.3-0.5 mg/ml), and 
was consistent with low affinity adsorptive pinocytosis 
[20]. Melanotransferrin [21] appeared to play little role in 
Fe uptake from Tf [16,19,22-24]. Further work demon- 
strated that preincubation of melanoma cells with FAC 
resulted in down-regulation f the specific Tf-binding site 
[25]. Paradoxically, FAC also markedly stimulated the rate 
of Fe uptake from Tf at Tf concentrations above that 
required for saturation of the TfR, without increasing the 
rate of Tf uptake [25]. It was hypothesized that FAC may 
be acting to stimulate the postulated iferric Tf reductase 
by acting as an electron acceptor, enhancing electron trans- 
port across the membrane and increasing Fe uptake from 
Tf. It was relevant to investigate this hypothesis as it may 
have important consequences in defining the relative roles 
of the two main mechanisms of Fe uptake from Tf, namely 
RME and the alternate process mediated by an oxidoreduc- 
tase. Additionally, as described above, previous work in 
other cell types has demonstrated that FAC can also 
stimulate the uptake of Fe from small M r Fe complexes. 
However, the mechanism responsible for activating this Fe 
uptake system was not established [ 17], and hence, it was 
also of interest o examine the relationship between FAC 
stimulated Fe uptake from Tf and small M r Fe complexes. 
The present study demonstrates that FAC stimulates 
59Fe uptake from 59Fe-125I-Tf and 59Fe-citrate by a novel 
Fe transport mechanism which does not involve the TfR or 
a diferric Tf reductase. This Fe uptake system is activated 
by hydroxyl radicals produced via the Fe-catalysed 
Haber-Weiss reaction, and it is suggested that this process 
may be an important protective mechanism to guard against 
oxidant stress generated in the presence of small M r Fe 
complexes in pathophysiological states such as Fe over- 
load disease. 
2. Materials and methods 
2.1. Reagents 
All reagents were obtained from the same suppliers as 
described previously [16,23,25]. 
2.2. Cells 
The SK-Mel-28 human melanoma cell line was ob- 
tained from the American Type Culture Collection (ATCC, 
Rockville, MD) and Chinese hamster ovary cells (wild 
type and variant A (Va) mutant deficient in the TfR) were 
kind gifts from Dr. F.R. Maxfield [26]. Cells were grown 
and subcultured as described by Richardson and Baker 
[191. 
2.3. Protein purification and labelling 
Human apoTf was prepared and labelled with 59Fe and 
1251 as described [19]. Apolactoferrin (ALF) was labelled 
with 56Fe using the same technique described above for 
apoTf. Monoclonal antibodies (MoAb) specific for the 
human TfR (42/6) and human Tf (HTF-14) were kind 
gifts from Dr. I. Trowbridge (Salk Institute, San Diego, 
CA) and Dr. A. Hradilek (Institute of Hematology and 
Blood Transfusion, Prague), respectively. 
2.4. Experimental procedure-uptake of iron and transferrin 
after exposure to ferric ammonium citrate 
2.4.1. Preincubation procedure 
Cells were preincubated with MEM (control) or MEM 
containing FAC (25 /xg/ml;[Fe] = 4 /zg/ml) using three 
45 min incubations at 37°C [24], as this procedure was 
found to be most effective at stimulating 59Fe uptake from 
59Fe-125I-Tf [24]. FAC at concentrations upto 150/zg/ml 
([Fe] = 26 /zg/ml) had no adverse effects on cells, as 
judged by LDH release, uptake of 3H-leucine, trypan blue 
staining and cellular adherence. Furthermore, FAC has 
been commonly used at this concentration to load cells 
with Fe with no deleterious consequences [27-29]. 
2.4.2. Labelling procedure 
After the preincubation procedure, the medium was 
replaced with medium containing 59Fe-125I-Tf ([Tf] = 0.1 
mg/ml; [Fe] = 2.5 /zM) or 59Fe-citrate (1:100; [Fe] = 2.5 
/xM) which was then incubated with the cells for 2 h. It 
should be noted that a 1:100 molar ratio of 59Fe to citrate 
was used to prevent polymerisation [30,31 ]. Previous tud- 
ies investigating low-M r Fe uptake have used nitrilotri- 
acetic acid (NTA) to chelate 59Fe [15,17,32]. However, 
NTA is a non-physiologically relevant ligand, and in the 
. • - 59  - present investigation Fe-otrate was used as this is the 
prevailing form of non-Tf-bound Fe found in the serum of 
patients with Fe-overload [33]. In addition, earlier studies 
using melanoma cells demonstrated that 59Fe donated to 
the cell from citrate- 59 Fe is efficiently intemalised and 
incorporated into ferritin and other compartments [ 16]. 
In some experiments various agents were added to the 
preincubation or labelling solutions to assess their effects 
on Fe uptake from Tf or Fe-citrate. When alteration to the 
standard procedures are implemented, they are described in 
the text. After incubation with 59Fe-125I-Tf or 59Fe-citrate, 
the medium was removed and the cells washed 4-times 
with ice-cold balanced salt solution. Pronase (1 mg/ml) 
was then incubated with the cells for 30 min at 4°C to 
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separate internalised from membrane-bound 59Fe and t25I- 
Tf, as described [19,25,34] 
Results were calculated as moles of Fe or Tf per gram 
of protein (gPR) and as a percentage of the control and are 
expressed as the mean or mean + S.D. Each determination 
was derived from 1 confluent petri dish containing 5 × 106 
cells, and this was equivalent to about 0.45 mg of protein 
via the bicinchoninic acid protein assay procedure [19]. 
3. Resu l t s  
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3.1. Effect of ferric ammonium citrate concentration on 
iron uptake from transferrin 
The 59Fe uptake from Tf increased as the FAC concen- 
tration increased, and then plateaued at FAC concentra- 
tions from 25-75 /.~g/ml, where 59Fe uptake varied from 
194 ___ 4% (4 determinations) to 184 + 4% (4 determina- 
tions) of the control value, respectively (Fig. 1). Increasing 
the FAC concentration to more than 75 /zg/ml  decreased 
59Fe uptake from Tf, and at a FAC concentration of 150 
/ zg /ml ,  59Fe uptake decreased to approx. 62_  1% (4 
determinations) of the control (Fig. 1). At present we do 
not understand why there is a decrease in intemalised Fe 
uptake at high FAC concentrations. However, it should be 
noted that the decrease itn Fe uptake was not due to 
toxicity associated with FAC, as there was no change in 
cellular viability or adherence of the cells to the culture 
substratum. As a FAC concentration of 25 /zg /ml  was the 
minimum required to obtain maximum stimulation of 59Fe 
uptake (Fig. 1), this concentration was used in all other 
experiments. 
Exposure of cells to FAC for only 5 min was sufficient 
to produce enhanced Fe uptake after a 2 h incubation with 
Tf (data not shown), suggesting that de novo synthesis of a 
transporter did not occur. Ferric ammonium citrate- 
activated Fe uptake is not unique to SK-Mel-28 melanoma 
cells, and was seen in all cells examined, including Chi- 
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Fig. 1. The effect of ferric ammonium citrate (FAC) concentration 
(0.5-150 /zg/ml) on intemalised 59Fe uptake from 59Fe-125I-Tf (0.1 
mg/ml) by melanoma cells. Results are the mean + S.D. of 3-5 determi- 
nations in a typical experiment of 2 experiments performed. 
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Fig. 2. The effect of incubation time with (a) 59Fe-lZSI-Tf (0.1 mg/ml;  
[Fe]= 2.5 p.M) or (b) 59Fe-citrate ([Fe]= 2.5 /~M; molar ratio of 
59Fe:citrate= 1:100) on internalised 59Fe uptake by melanoma cells 
preincubated with MEM or MEM containing ferric ammonium citrate 
(FAC). Results are the means of 2 determinations i  atypical experiment 
of 3 experiments performed. The variation between duplicates was less 
than 5%. 
nese hamster ovary (CHO) cells (Va mutant and wild-type), 
human baby foreskin fibroblasts (provided by Dr. R. Ger- 
minario, Lady Davis Institute, Montreal) and a human 
embryonic kidney cell line (ATCC CRL 1573). However, 
as the Fe metabolism of the melanoma cell is well charac- 
terised [16,19,20,22-25,35], and since our initial report on 
the FAC-activated mechanism was performed using these 
cells [25], we decided to further characterise this process 
using the SK-Mel-28 melanoma cell line. 
3.2. Effect of incubation time with 59Fe-~25I-transferrin or
citrate-59Fe complexes on ferric ammonium citrate- 
activated iron uptake 
To examine the effect of incubation time with 59Fe- 
1251-Tf (0.1 mg/ml ;  [Fe] = 2.5 /~M) on FAC-activated 
59 Fe uptake, cells were exposed to MEM or MEM contain- 
ing FAC as described, and then incubated with Tf for up to 
3 h. Interestingly, FAC-activated 59Fe uptake was only 
observed after 60 min of incubation with Tf (Fig. 2a). In 
contrast, when melanoma ceils were treated with FAC and 
then exposed to 59Fe-citrate ([Fe] = 2.5 tzM), stimulation 
of 59Fe uptake was observed after only 1 min of incubation 
(Fig. 2b). The extent of stimulation with 59 Fe-citrate as an 
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Fe donor was far greater than that obtained with 59Fe-Tf, 
viz. after a 2 h incubation with 59Fe-citrate, FAC stimu- 
lated Fe uptake was 23-fold greater than that seen for the 
control (Fig. 2b). To investigate the mechanism responsi- 
ble for the FAC-activated Fe uptake process, experiments 
were designed to examine whether 59Fe uptake occurred 
by the diferric Tf reductase or RME. 
3.3. The role of the diferric transferrin reductase (oxido- 
reductase) in ferric ammonium citrate-activated iron up- 
take 
Considering our results demonstrating the stimulatory 
effect of FAC on Fe uptake from Tf ([25] and this report), 
we hypothesized that FAC could be acting as an oxidant o 
enhance oxidoreductase activity [36,37], resulting in an 
increase in Fe uptake from Tf. To test this hypothesis other 
ox idants  were  invest igated .  Indeed,  
Hexammineruthenium(III) chloride and 1,2-naph- 
thoquinone-4-sulfonate both stimulate oxidoreductase ac- 
tivity [38], and in the present study also increased Fe 
uptake from Tf, although to a lesser extent than FAC 
(Table 1). However, other oxidants uch as indigotetrasul- 
fonate, ferricyanide [38] and unlabelled iferric Tf [39], 
had no stimulatory effect (Table 1). In addition, amiloride, 
vanadate and chloroquine are all inhibitors of oxidoreduc- 
tase activity [5,7,39,40]. However, when amiloride (0.2 
raM) was added to 59Fe-125I-Tf,  it had little effect on 59Fe 
uptake by control cells or cells preincubated with FAC 
(Table 2), whereas vanadate and chloroquine decreased Fe 
uptake by control cells but had no effect on FAC-activated 
Fe uptake (data not shown). Collectively these data suggest 
that an oxidoreductase may not be responsible for FAC- 
activated 59Fe uptake from Tf. 
Table 2 
Effect of monoclonal antibody, 42/6,  and inhibitors of receptor-mediated 
endocytosis and oxidoreductase activity on iron uptake by the ferric 
ammonium citrate (FAC)-activated process 
Preincubation Labelling Internalised iron 
Incubated with: Incubated with: (% control) 
MEM (control) Tf 100 
FAC Tf 210 
MEM Tf+ Amiloride (0.2 raM) a 93 
FAC Tf+ Amiloride (0.2 mM) a 192 
MEM Tf+NH4Cl (15 mM) 15 
FAC Tf+ NH4C1 (15 mM) 132 
MEM T f+42/6  (100/xg/ml)  35 
FAC T f+42/6  (100 g~g/ml) 161 
Cells were preincubated with MEM or MEM-containing FAC (25/.Lg/ml) 
for three 45 rain incubations at 37°C. This medium was removed and the 
cells then labelled for 2 h at 37°C with ~gFeD25I-Tf (0.1 mg/ml )  in the 
presence and absence of the inhibitors. 
a Amiloride at concentrations up to 2 mM had a similar effect. 
Results are mean values of 2-3 determinations from a typical experiment 
of 3 experiments performed. The variation between duplicates or tripli- 
cates was less than 5%. 
3.4. The role of receptor-mediated ndocytosis in ferric 
ammonium citrate-activated iron uptake 
Ammonium chloride (NH4C1; 15 mM) is an inhibitor of 
endosomal acidification [41], and when incubated with Tf 
this agent reduced 59Fe uptake to 15% of the control in 
cells preincubated with MEM (Table 2). When NH4C1 was 
included with 59Fe-Tf after the initial preincubation with 
FAC, there was also a decrease in 59Fe uptake (Table 2). 
However, this decrease can be accounted for by the inhibi- 
tion of Fe uptake via the endocytotic processes, and hence, 
there has been no decrease in Fe uptake via the FAC- 
Table 1 
The effect of preincubation with ferric ammonium citrate (FAC) or other oxidants on internalised iron uptake from transferrin by SK-MEL-28 melanoma 
cells 
Oxidant % Control 
Internalised Fe Intemalised Tf 
MEM (Control) 
FAC (25/xg/ml)  
Citrate (25/~g/ml) 
Unlabelled iferric Tf (2.5/xM) 
Hexammineruthenium(III) chloride (0.1 mM) 
Hexammineruthenium(III) chloride (0.5 raM) 
1,2-Naphthoquinone-4-sulfonate (0.1 mM) 
Indigotetrasulfonate (0.1 mM) 
Ferricyanide (0.5 mM) 
Ferrocyanide (0.5 mM) 
Cytochrome c (1 mg/ml)  
1004- 1 a 100+3 
205 + 6 105 + 5 
98 + 3 102 + 1 
88 b 95 
145 + 4 104 + 2 
162 + 7 105 + 5 
129 + 6 103 + 1 
95 + 3 102 + 3 
103 + 3 96 + 3 
105 + 5 102 + 4 
94+3 98+3 
Cells were preincubated with the oxidants using three 45 min incubations at 37°(2. The medium was then removed and replaced with medium containing 
SgFe-t2SI-Tf (0.1 mg/ml )  which was incubated with the cells for 2 h at 37°C. 
a Results are mean + S.D. (3 determinations) from a typical experiment of 2-3 experiments performed. 
b Results are mean values of duplicate determinations from a typical experiment of 2 experiments performed. The variation between duplicates was less 
than 5%. 
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activated process (Table 2). To further test whether FAC- 
activated Fe uptake was mediated by the TfR, the effect of 
MoAb 42/6 which prevents the binding of Tf to the TfR 
[42] was also examined. When this MoAb (100 /xg/ml) 
was added together with 59 Fe-125 I-Tf, it markedly reduced 
59Fe uptake to 35% of the control value in cells preincu- 
bated with MEM (Table 2). On the other hand, for cells 
preincubated with FAC, the decrease in 59Fe uptake seen 
after incubation with Tf and 42/6 (Table 2), can be 
accounted for by the inhibition of the endocytotic process, 
and hence, this MoAb had no significant effect on the 
FAC-activated mechanism. 
Further evidence that the TfR is not involved in FAC- 
activated Fe uptake was obtained by examining the effect 
of FAC on 59Fe uptake from 59Fe-lZSI-Tf by wild-type 
(WT) Chinese hamster ovary (CHO) cells expressing the 
TfR and mutant (Va) CHO cells deficient in TfR expres- 
sion [26,43]. Comparison of intemalised 59Fe uptake by 
the WT and Va CHO cell,; preincubated with MEM only 
(Table 3), demonstrated that Va cells can obtain little Fe 
from Tf. However, for both cell types, preincubation with 
FAC effectively stimulated Fe uptake (Table 3). After 
exposure to FAC, intemalised 59Fe uptake from Tf was 
equivalent to 159% and 2400% of the control values (i.e., 
MEM) for the WT and Va cell lines, respectively (Table 
3). Interestingly, a large increase in membrane 59Fe uptake 
by both wild-type and mutant CHO cells also occurred 
after activation with FAC, which may indicate the pres- 
ence of an membrane-bound Fe binding component (Table 
3). Further, there was also an increase in the internalised 
molar ratio of Fe:Tf, and this was particularly marked for 
Va cells, where it increased from 8 (control) to 98 (FAC- 
activated). In addition, for Va cells, the percentage of the 
total 59Fe which was intemalised after exposure to FAC 
increased from 30% to 74%, whereas there was no in- 
crease in the percentage of 125I-Tf internalised (Table 3). 
These data, together with that described above, clearly 
demonstrate hat the TfR is not required for FAC-activated 
Fe uptake. 
To further characterise FAC-activated Fe uptake from 
Tf, the effect of temperature was also investigated. When 
cells were preincubated with FAC at 4°C instead of 37°C, 
and then labelled with Tf at 37°C, FAC at 4°C was still 
able to stimulate 59Fe uptake from S9Fe-Tf to 153% of the 
control. However, if the cells were preincubated with FAC 
at 37°C as usual, and then labelled with Tf at 4°C, there 
was no uptake of 59Fe from 59Fe-Tf, suggesting that the 
cell must be metabolically active to remove Fe from Tf. 
3.5. Does the ferric ammonium citrate-activated process 
remove iron from transferrin at the cell surface and does it 
require direct interaction of transferrin with the plasma 
membrane ? 
To examine the mechanism of Fe release from Tf by the 
FAC-activated process, cells preincubated with MEM or 
FAC were then labelled with 59Fe-125I-Tf (0.1 mg/ml) 
containing apolactoferrin (ALF; 0.3 mg/ml) or diferric 
lactoferrin (DLF; 0.3 mg/ml), neither of which binds to 
the TfR [44]. When ALF was added together with Tf, and 
then incubated with cells previously exposed to FAC, ALF 
completely prevented FAC-activated Fe uptake (Table 4). 
ALF had no effect on Fe uptake from Tf in control cells 
preincubated with MEM only. In contrast, DLF had little 
effect on 59Fe uptake in cells preincubated with FAC or 
MEM (Table 4). These results suggest that after activation 
with FAC, Fe was released from Tf at the outer cell 
membrane or in solution and then chelated by ALF. 
Previous work has demonstrated that melanoma cells 
have only one class of Tf-binding sites [19,20], which as 
shown above, are not involved in FAC-activated Fe up- 
take. In addition, FAC-activated Fe uptake was not due to 
an increase in the activity of the adsorptive pinocytosis 
pathway [20], as there was no increase in the rate of 
Table 3 
Effect of preincubation with ferric ammonium citrate (FAC) on iron uptake from 59Fe-J2~I-transferrin (0.1mg/ml) by wild-type and variant A (Va) 
Chinese hamster ovary cells deficient inthe transferrin receptor 
Intern.Fe Intern. Fe:Tf Memb. Fe %Fe Intern. %Tf Intern. 
(% Control) (% Control) 
Control 100 + 4 59 5:1 100 5:6 91 5:1 29 5:2 
Wild type a (42.3) (4.4) 
FAC 159 5:3 74 5:1 220 5:13 87 5:1 30 5:3 
Wild type (67.1) (9.7) 
Control 100 + 6 8 + 1 100 + 9 30 5:1 9 5:1 
Va (1.2) (2.8) 
FAC 2400 5:65 98 + 6 357 + 34 74 5:2 10 5:1 
Va (28.8) (10.0) 
Cells were preincubated with MEM (control) or MEM containing FAC (25 /~g/ml) for three 45 min incubations at 37°C. This medium was removed and 
the cells then labelled with SaFe-125I-Tf (0.1 mg/ml) for 2 h at 37°C. 
Results are mean + S.D. (4-5 determinations) from a typical experiment of two experiments performed. 
a Results in parentheses r present Feuptake xpressed asnmole Fe/gPR. 
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Table 4 
The effect of apolactoferrin (ALF) and diferric lactoferrin (DLF) on 
intemalised 59Fe uptake from 59Fe-1251-Tf bymelanoma cells 
Preincubation Labelling Intemalised iron 
Incubated wi th :  Incubated with: (% Control) 
MEM (control) Tf 100 
FAC + MEM Tf 244 
MEM Tf + ALF 94 
FAC + MEM Tf+ ALF 87 
MEM Tf + DLF 91 
FAC + MEM Tf + DLF 235 
Cells were preincubated with MEM (control) or MEM-containing FAC 
(25/zg/ml) for three 45 min incubations. This medium was removed and 
the cells then labelled for 2 h at 37°C with 59Fe-125I-Tf (0.1 mg/ml) 
only, or 59 Fe- 125i_Tf (0.1 mg/ml) and ALF (0.3 mg/ml), or 59 Fe- J25i_Tf 
(0.1 mg/ml) and DLF (0.3 mg/ml). The results are the means of 2 
determinations i  a typical experiment of 3 experiments performed. The 
variation between duplicates was less than 5%. 
non-specific Tf uptake [25]. Moreover, FAC-activated Fe 
uptake was only observed at Tf concentrations above that 
required for saturation of the TfR (i.e., > 0.01 mg/ml ;  
[25]). These data together with the fact that non-specific 
adsorption increases linearly with Tf concentration after 
saturation of the TfR [20], could indicate that FAC- 
activated Fe uptake is mediated by non-specific adsorption 
of Tf to the cell membrane. 
To investigate whether specific-binding of 59Fe-12SI-Tf 
to the cell membrane was required for FAC-activated Fe 
uptake, the effect of the anti-Tf MoAb, HTF-14 (HTF), 
was examined. Previous studies by Hradilek and Neuwirt 
[45] have demonstrated that treatment of 59Fe-125I-Tf with 
HTF results in an immune complex which prevents Tf 
from interacting with the specific TfR and also inhibits Fe 
uptake. In the present study, HTF (0.1 mg/ml )  was incu- 
bated for 3 h at 37°C with 59Fe-l:SI-Tf (0.1 mg/ml )  to 
produce 59Fe-I25I-Tf-HTF complexes (Tf-HTf). Preincuba- 
tion of cells with MEM followed by incubation with 
Tf-HTF decreased 59Fe uptake to 8% of that found when 
control cells were incubated with 59Fe-lESI-Tf. However, 
when cells were preincubated with FAC and then exposed 
to Tf-HTF, 59Fe uptake was 53% of that found when these 
cells were incubated with ~9Fe-125I-Tf alone. This HTF- 
mediated ecrease in 59Fe uptake observed in FAC-treated 
cells can be accounted for by the inhibition of specific 
RME and the non-specific adsorptive pinocytosis process 
in these cells [20]. Hence, the FAC-activated process could 
still efficiently remove Fe from Tf, even though the HTF-Tf 
immune complex could prevent he specific interaction of 
Tf with the cell membrane. These results may suggest hat 
the Tf-HTF immune complex keeps Tf out of contact with 
the cell surface and that Fe uptake mediated via the 
FAC-activated process occurs in solution. Alternatively, 
the FAC-stimulated mechanism ay only remove Fe from 
Tf when the HTf-Tf immune complex becomes non- 
specifically adsorbed to the cell membrane. 
Evidence that non-specific adsorption of Tf to the cell 
surface is required for FAC-activated Fe uptake is sug- 
gested by the fact that when BSA (70 mg/ml )  was added 
with 59Fe-~25I-Tf (0.1 mg/ml ) ,  it completely inhibited 
FAC-activated Fe uptake, while having no effect on Fe 
uptake by control cells (data not shown). Concentrations of
BSA less than 70 mg/ml  were far less effective at pre- 
venting internalised Fe uptake. For example, BSA added to 
Tf at concentrations from 1-5 mg/ml  had no effect on 
FAC-activated Fe uptake, whereas BSA at a concentration 
of 40 mg/ml  resulted in only a 46% decrease in Fe uptake 
by the FAC-stimulated process. It is also important to note 
that FAC-activated Fe uptake is observed only after 60 
min of incubation with Tf (Fig. 2a), whereas stimulation 
from Fe-citrate was evident after only 1 min of incubation 
with this complex (Fig. 2b). Since it is generally known 
that non-specific adsorption increases with increasing incu- 
bation time, these results suggest hat FAC-stimulated Fe 
uptake from Tf is a process mediated by non-specific 
adsorption to the cell membrane. On the other hand, 59Fe 
uptake from citrate may be the result of direct interaction 
with the same transport mechanism. 
3.6. The effect of free radical scavengers on iron uptake 
To examine whether free radicals played a role in 
FAC-activated Fe uptake, catalase and superoxide dismu- 
tase (Table 5) were added to FAC. These enzymes were 
found to be highly effective at preventing FAC-activated 
Fe uptake from Tf. In contrast, BSA added as a protein 
control at an equivalent concentration (0.05 mg/ml )  had 
no effect on Fe uptake (Table 5). Other radical scavengers 
such as Hepes [46], desferrioxamine (DFO), mannitol or 
high concentrations of ascorbic acid (5 mM; [47]) or BSA 
Table 5 
The internalised iron uptake by SK-MEL-28 cells after the addition of 
catalase (1000 U/ml) and/or superoxide dismutase (SOD; 1000 U/ml) 
to the preincubation solutions 
Preincubation Labelling Internalised Fe
Incubated with: Incubated with: (% Control) 
MEM (control) Tf 100 4-10 
FAC Tf 181 +4 
BSA a + FAC Tf 176 + 5 
Catalase +MEM Tf 107 4- 3 
Catalase +FAC Tf 95 4-1 
SOD + MEM Tf 100 + 8 
SOD+FAC Tf 124-t-4 
Catalase +SOD + FAC Tf 82 4- 8 
Cells were preincubated with MEM or FAC (25 /.Lg/ml) in the presence 
and absence of catalase or SOD or both for three 45 min incubations at
37°C. This medium was removed and the cells then labelled with 
59Fe-lESI-Tf (0.1 mg/ml) for 2 h at 37°C. Results are mean+S.D. (3 
determinations) from a typical experiment of2 experiments performed. 
a BSA was used as a protein control at an equivalent concentration to 
catalase and SOD, and at the low concentration used (0.5 mg/ml), did 
not inhibit FAC-stimulated 59Fe uptake from 39Fe-J25I-Tf. 
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Table 6 
The internalised iron uptake by SK-MEL-28 cells after the addition of 
ceruloplasmin, ascorbate, desferrioxamine, thebuffer Hepes, mannitol or 
bovine serum albumin (BSA) to the preincubation solution 
Preincubation Labelling Intern. Fe 
Incubated with: Incubated with: (% Control) 
MEM (control) Tf 100 + 7 
FAC Tf 218 + 15 
MEM + Ceruloplasmin (85 U/ml) Tf 113 + 6 
FAC + Ceruloplasmin (85 U/ml) Tf 90 + 1 
MEM + Ascorbate (0.5 mM) Tf 117 + 7 
FAC + Ascorbate (0.5 mM) Tf 156 + 4 
MEM + Ascorbate (5 mM) Tf 95 + 5 
FAC + Ascorbate (5 raM) Tf 104 + 6 
MEM + DFO (0.5 mM) Tf 101 + 8 
FAC + DFO (0.5 mM) Tf 90 + 6 
MEM + Hepes (20 mM) Tf 105 + 5 
FAC + Hepes (20 raM) Tf 112 + 4 
MEM + Mannitol (5 mM) Tf 99 + 1 
FAC + Mannitol (5 raM) Tf 115 + 1 
MEM + BSA (50 mg/ml) Tf 115 +4 
FAC + BSA (50 mg/ml) Tf 80 + 4 
Cells were preincubated with MEM (control) or MEM containing FAC 
(25 /xg/ml) in the presence of various free radical scavengers for three 
45 min incubations at37°C. This medium was removed and the cells then 
labelled with S9Fe-125I-Tf (0.1 mg/ml) for 2 h at 37°C. Results are 
mean + S.D. (3 determinations) fi'om a typical experiment of2-3 experi- 
ments performed. 
(50 mg/ml ;  [48]) when added with FAC almost com- 
pletely prevented FAC-activated 59Fe uptake (Table 6). 
Titration experiments demonstrated that BSA added to 
FAC at a concentration of 1 mg/ml  had no effect on 
FAC-stimulated Fe uptake and that concentrations greater 
than 30 mg/ml  were necessary to completely block this Fe 
uptake process. The ferroxidase, ceruloplasmin (Table 6), 
which prevents free radical formation by oxidising Fe(II) 
to Fe(III) [49], also prevented FAC-activated 59Fe uptake. 
Furthermore, all these agents when added to MEM alone 
had no effect on 59Fe uptake from Tf. Also, as found for 
Tf, the addition of catalase and HEPES to FAC markedly 
prevented the stimulated 59 Fe uptake seen from 59 Fe-citrate 
(Table 7). These data suggest that the initial activation 
event may be due to the production of free radicals from 
FAC via the Fe-catalysed Haber-Weiss reaction. For 
proper interpretation of these results, understanding of the 
redox chemistry involved is required, and is summarised in
the equations below: 
Fe(I I I )  + 0 2- ~ Fe(I I )  + 0 2 (1) 
Fe( I I )  + H202 ~ OH+ OH-+ Fe( I I I )  (2)  
iron 
Net:O 2- + H202 ~ 02 + OH+ OH-  (3) 
catalyst 
Eq. (2) is the Fenton reaction [50]; eq. (3) is the 
iron-catalysed Haber-Weiss reaction [51]. Hence, the ac- 
tive oxygen species involved in stimulating Fe uptake may 
be the superoxide radical (O2-), hydrogen peroxide 
(H202), and or the hydroxyl radical (OH)  [50]. Superox- 
ide dismutase removes O2-, whereas catalase removes 
H202, and both proteins effectively prevented FAC- 
activated Fe uptake (Table 5). It is of interest hat both 
catalase and SOD can inhibit OH production by O2--gen- 
erating systems containing Fe [52]. Furthermore, Hepes, 
mannitol, DFO and high concentrations of BSA or ascor- 
bic acid, have been demonstrated to be scavengers of OH'  
[47,53], and all markedly prevented FAC-activated Fe 
uptake (Table 6). 
To further investigate the role of free radicals in the 
activation event, cells were preincubated with the O2--gen- 
erating agent, methylene blue (MB; [54]). When cells were 
preincubated with MB (0.1 mM) alone, and then incubated 
with 59Fe-125I-Tf, there was a decrease in intemalised Fe 
uptake to 52% of the control. In contrast, the addition of 
MB to FAC resulted in a marked increase in Fe uptake to 
302% of the control (results not shown). Similarly, the 
addition of another O2--generator, menadione (10 /xM; 
[55]), to FAC also markedly stimulated Fe uptake from 
59Fe-citrate (Table 8), whereas preincubation with mena- 
dione alone was far less effective at increasing Fe uptake. 
When H20 2 (0.9/zM) was added to cells it had no effect 
on Fe uptake from Fe-citrate, whereas the addition of 
Table 7 
The effect of catalase and the buffer Hepes on internalised 59Fe uptake from 59Fe-citrate complexes by melanoma cells 
Preincubation Labelling Internalised iron Internalised Iron 
(%Control) 
Incubated with: Incubated with: ( Ixmole Fe/gPR) 
MEM (control) Fe-citrate 0.04 100 
FAC + MEM Fe-citrate 0.82 2050 
Catalase +MEM Fe-citrate 0.04 100 
Catalase +FAC Fe-citrate 0.18 450 
Hepes + MEM Fe-citrate 0.04 100 
Hepes + FAC Fe-citrate 0.14 350 
Melanoma cells were preincubated with MEM or MEM-containing FAC (25/~g/ml) and also MEM- or FAC-containing catalase (1000 U/ml) or Hepes 
(20 mM) for three 45 min incubations at37°C. After this procedure, the cells were then labelled with 59Fe-citrate (2.5 /zM) for 2 h at 37°C. Results are 
means of 2 determinations i  a I:ypical experiment of3 experiments performed. The variation between duplicates was less than 5%. 
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Table 8 
The effect of the superoxide generator, menadione (Men), and also 
hydrogen peroxide (HP), on internalised 59Fe uptake from 59Fe-citrate 
complexes by melanoma cells 
Preincubation Labelling Internalised iron 
Incubated with: Incubated with: ( p.mole Fe/gPR) (% Control) 
MEM (control) Fe-citrate 0.03 100 
FAC + MEM Fe-citrate 0.64 2133 
Men + MEM Fe-citrate 0.07 233 
Men + FAC Fe-citrate 1.86 6200 
HP + MEM Fe-citrate 0.03 100 
HP + FAC Fe-citrate 0.89 2967 
Cells were preincubated with MEM or MEM-containing FAC (25 
/xg/ml), or MEM- or FAC (25/zg/ml)-containing Men (10/xM) or HP 
(0.9/zM) for three 45 min incubations at 37°C. After this procedure, the 
cells were then labelled with 59Fe-citrate (2.5 /xM) for 2 h at 37°C. 
Results are the means of 2 determinations in a typical experiment of 3 
experiments performed. The variation between duplicates was less than 
5%. 
H202 to FAC stimulated Fe uptake, although the extent of 
stimulation was not as great as that observed in the pres- 
ence of menadione (Table 8). 
The results described above suggest hat neither H20 2 
nor O~- alone were responsible for activation of the 
FAC-stimulated mechanism. However, the addition of 
H202 and 02- to FAC would result in an increase in the 
production of OH via the Fe-catalysed Haber-Weiss reac- 
tion (Eq. 3; [51]), and considering these data together with 
that listed in Table 5 and 6, it can be suggested that OH" 
may be the active agent. When the 02- generator, mena- 
dione, was added to FAC, it was far more effective than 
H202 at stimulating 59Fe uptake (Table 8). Relevant o 
this, Kaplan et al. [17] have demonstrated that Fe in the 
FAC complex is mainly in the Fe(III) oxidation state, with 
very little present as Fe(II). Hence, under the present 
experimental conditions, the production of Fe(II) is proba- 
bly the rate-limiting step in the Fe-catalysed Haber-Weiss 
reaction, since the addition of O~- results in the reduction 
of Fe(III) to Fe(II) (see Eq. 1), which drives the reaction 
towards the production of OH' (Eq. 3). Similarly, this may 
explain why SOD inhibits the FAC-activated Fe uptake 
process (Table 5), as the reduction of Fe(III) to Fe(II) 
would not occur in the absence of O2-. 
4. Discussion 
The present study suggests that the initial stimulation of 
FAC-activated Fe uptake from Tf and Fe-citrate may be 
caused by the production of OH" via the Fe-catalysed 
Haber-Weiss reaction. This mechanism of Fe uptake is not 
only found in human melanoma cells, but it is also present 
in human fibroblasts, a human embryonic kidney cell line 
and Chinese hamster ovary cells, suggesting that it may be 
of widespread significance. In addition, Kaplan et al. [17] 
examining the stimulatory effect of FAC on Fe uptake 
from Fe-NTA, also found that this process is present in a 
wide range of cell types, including skin fibroblasts, HeLa 
cells, L-cells and a hepatocellular carcinoma (Hep-G2) cell 
line. However, these latter authors did not establish the 
mechanism of how FAC stimulated Fe uptake or the fact 
that preincubation of cells with FAC can also markedly 
increase Fe uptake from Tf. Our present experiments clearly 
demonstrate hat FAC-activated Fe uptake from Tf is not 
due to either RME or the postulated iferric Tf reductase, 
but represents a previously unrecognised mechanism which 
may also be involved in Fe uptake from small M r com- 
plexes. When FAC-activates this process, Fe is efficiently 
internalised within the cell (Fig. 2a and b) where it can be 
used for metabolic functioning or stored in ferritin. More- 
over, Fe accumulated after treatment with FAC enters 
physiologically relevant intracellular Fe pools, as it results 
in an accumulation of ferritin-Fe and down-regulation of
the TfR [17,25]. 
The observation that OH can markedly stimulate Fe 
uptake may have important physiological nd pathophysio- 
logical consequences. There is a large body of evidence 
suggesting that free radicals play an important role in the 
pathogenesis of many human diseases, including Fe over- 
load [47,56-61]. The OH radical can be formed under 
physiological nd pathophysiological onditions in vivo by 
(A), the Fe-catalysed Haber-Weiss reaction, utilising 0 2- 
generated by normal aerobic metabolism or via xanthine 
oxidase in post-ischaemic tissues [62], and (B) via the 
Fe-independent peroxynitrite pathway [63]. In Fe overload 
disease for example, high concentrations of serum non-Tf- 
bound Fe exists in the form of Fe-citrate [33,64], which is 
capable of creating free radicals via the Fe-catalysed 
Haber-Weiss reaction [65,66]. In these diseases non-Tf- 
bound Fe can reach concentrations higher than those used 
in our experiments (i.e., > 70 /xM; [60,65]), and hence, 
the Fe-loading seen in these diseases may be partly due to 
the OH-activated Fe uptake process. It can be suggested 
that by removing extracellular low-M r Fe and storing it 
intracellularly in ferritin for example, the cell prevents 
OH -mediated lipid peroxidation of its plasma membrane 
and the consequential cellular injury or death. 
High concentrations of BSA prevented the non-specific 
interaction of Tf with the cell membrane that was neces- 
sary for FAC-activated Fe uptake. Moreover, cerulo- 
plasmin and high concentrations of BSA also prevented 
stimulation when added to FAC (Table 6), probably due to 
their ferroxidase [49] and non-specific free radical scav- 
enging properties [48], respectively. Therefore, in the 
plasma, ceruloplasmin a d the high concentrations of serum 
proteins may prevent the FAC-activated process. However, 
an albumin concentration f > 30 mg/ml was essential to 
completely prevent activation when BSA was added to 
FAC, and a BSA concentration f 70 mg/ml was required 
to preclude the non-specific binding of Tf that was neces- 
sary for FAC-activated Fe uptake. These observations are 
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crucial regarding the physiiological relevance of the FAC- 
stimulated mechanism, as the concentrations of albumin 
and ceruloplasmin are far reduced in the interstitial fluid 
that comes into direct contact with cells. For instance, 
while the protein concenmttion of plasma is = 73 mg/ml 
([albumin] = 44 mg/ml), the protein concentration of the 
interstitial f uid at the arterial ends of capillaries may be as 
low as 3 mg/ml ([albumin] = 1.8 mg/ml; [67]). Schmidt 
and Thews [67] have stated that an acceptable estimate of 
the mean protein concentJ;ation of the interstitial fluid is 
18-20 mg/ml ([albumin]= 11-12 mg/ml), and under 
these conditions the FAC-activated mechanism could take 
place. Also, in Fe overload disease where there is a high 
concentration of non-Tf-bound Fe, there is evidence that 
antioxidant defenses are overwhelmed. For example, de- 
spite elevated ceruloplasmin concentrations in haemochro- 
matosis patients with high levels of non-Tf-bound Fe, 
serum from these patients can stimulate lipid peroxidation 
[65]. This report suggests that in vivo non-Tf-bound Fe 
results in oxidative damage despite the presence of albu- 
min and ceruloplasmin, and under these circumstances the 
FAC-activated process may occur. 
It can be argued that the concentration of Tf in the 
interstitial fluid is also reduced compared to the plasma. 
However, in Fe overload disease Tf is almost fully satu- 
rated with Fe [2], and considering that the plasma Tf 
concentration is ~ 2.3 mg/ml [2], and that the Tf concen- 
tration of the interstitial fluid is about one-third this value 
(0.8 mg/ml; [68]), it is clear that this Tf concentration is 
far greater than that required for saturation of the TfR 
(0.01 mg/ml; [19,25]). Therefore, the Tf concentration i  
the interstitial fluid is probably suitable for acting as a 
substrate for the FAC-activated Fe uptake process. 
Considering the question of how OH' activates this Fe 
uptake mechanism, it can be suggested that a genetic 
mechanism is probably not involved, since exposure of 
cells to FAC for only 5 min was sufficient o produce 
enhanced Fe uptake after a 2 h incubation with Tf. Kaplan 
et al. [17], investigating the effect of FAC on Fe uptake 
from Fe-NTA by flbrobl~.sts, have suggested that the in- 
creased rate of Fe uptake ~aaay be due to the recruitment of 
a cryptic pool of transporters to the cell surface. Such a 
mechanism could occur quite rapidly and may explain the 
results of the present investigation. However, further stud- 
ies are required to characterise the molecular mechanism 
responsible for FAC-activated Fe uptake. 
In conclusion, incubation of cells with FAC results in 
the production of OH which activates a membrane-bound 
Fe transport system that ils capable of binding and trans- 
porting Fe in the form of low-M r complexes. Furthermore, 
as a secondary consequence of its activity, this OH-  
stimulated Fe uptake system can also remove Fe from Tf 
when the Tf becomes non-specifically adsorbed to the cell 
membrane. This latter observation could indicate that pro- 
cesses of reduction and/or protonation are occurring which 
are sufficient o remove Fe from the high affinity binding 
sites of Tf. We speculate that the FAC-activated Fe uptake 
process represents a protective mechanism to guard against 
oxidant stress generated from low-M r Fe complexes which 
may be important in pathophysiological states such as 
Fe-overload isease. 
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